Literature DB >> 16202924

Molecular signaling through G-protein-coupled receptors and the control of intracellular calcium in myometrium.

Barbara M Sanborn1, Chun-Ying Ku, Sergiy Shlykov, Lidiya Babich.   

Abstract

Cellular mechanisms regulating myometrial intracellular free calcium (Ca2+(i)) are addressed in this review, with emphasis on G-protein-coupled receptor pathways. An increase in myometrial Ca2+(i) results in phosphorylation of myosin light chain, an increase in myosin adenosine monophosphatase (ATPase) activity and contraction. Dephosphorylation of myosin light chain and a decline in Ca2+(i) are associated with relaxation. Increases in Ca2+(i) are controlled by multiple signaling pathways, including receptor-mediated activation of phospholipase Cbeta (PLCbeta), leading to release of Ca2+ from intracellular stores. Ca2+ also enters myometrial cells through plasma membrane Ca2+ channels. Conversely, adenosine triphosphate (ATP)-dependent Ca2+ pumps lower Ca2+(i) concentrations and potassium channels promote hyperpolarization that can decrease Ca2+ entry. Receptor-coupled pathways that promote uterine relaxation primarily involve activation of cyclic adenosine monophosphate (cAMP)- or cyclic guanosine monophosphate (cGMP)-stimulated protein kinases that phosphorylate proteins regulating Ca2+ homeostasis. cAMP has inhibitory effects on myometrial contractile activity, agonist-stimulated phosphatidylinositide turnover and increases in Ca2+(i). Some of these effects require association of protein kinase A (PKA) with a plasma membrane-associated A-kinase-anchoring-protein (AKAP). Near term in the rat, there is a decline in the plasma membrane localization of PKA associated with this anchoring protein. This correlates with changes in the regulation of signaling pathways controlling Ca2+(i). L-type voltage-operated Ca2+ entry is an important regulator of myometrial contraction. In addition, putative signal-regulated or capacitative Ca2+ channel proteins, TrpCs, are expressed in myometrium, and signal-regulated Ca2+ entry is observed in human myometrial cells. This Ca2+ entry mechanism may play a significant role in the control of myometrial Ca2+(i) dynamics and myometrial contraction. The regulation of myometrial Ca2+(i) is complex. Understanding the mechanisms involved may lead to design of tocolytics that target multiple pathways and achieve improved suppression of premature labor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202924     DOI: 10.1016/j.jsgi.2005.07.002

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  17 in total

Review 1.  Hormonal signaling and signal pathway crosstalk in the control of myometrial calcium dynamics.

Authors:  Barbara M Sanborn
Journal:  Semin Cell Dev Biol       Date:  2007-05-18       Impact factor: 7.727

Review 2.  A close look at the contraction and relaxation of the myometrium; the role of calcium.

Authors:  Bilge Pehlivanoğlu; Sibel Bayrak; Murat Doğan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

3.  Bitter taste receptors as targets for tocolytics in preterm labor therapy.

Authors:  Kaizhi Zheng; Ping Lu; Ellen Delpapa; Karl Bellve; Ruitang Deng; Jennifer C Condon; Kevin Fogarty; Lawrence M Lifshitz; Tiffany A Moore Simas; Fangxiong Shi; Ronghua ZhuGe
Journal:  FASEB J       Date:  2017-05-30       Impact factor: 5.191

4.  Oxytocin (OXT)-stimulated inhibition of Kir7.1 activity is through PIP2-dependent Ca2+ response of the oxytocin receptor in the retinal pigment epithelium in vitro.

Authors:  Nathaniel York; Patrick Halbach; Michelle A Chiu; Ian M Bird; De-Ann M Pillers; Bikash R Pattnaik
Journal:  Cell Signal       Date:  2017-06-08       Impact factor: 4.315

5.  Interplay of transcriptional signaling by progesterone, cyclic AMP, and inflammation in myometrial cells: implications for the control of human parturition.

Authors:  Zachary Stanfield; Peyvand Amini; Junye Wang; Lijuan Yi; Huiqing Tan; Mark R Chance; Mehmet Koyutürk; Sam Mesiano
Journal:  Mol Hum Reprod       Date:  2019-07-01       Impact factor: 4.025

6.  Drug discovery strategies for the identification of novel regulators of uterine contractility.

Authors:  Shajila Siricilla; Chisom C Iwueke; Jennifer L Herington
Journal:  Curr Opin Physiol       Date:  2019-10-23

7.  Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle.

Authors:  Jonathon M Willets; Paul J Brighton; Rajendra Mistry; Gavin E Morris; Justin C Konje; R A John Challiss
Journal:  Mol Endocrinol       Date:  2009-05-07

8.  Multiple signals regulate phospholipase CBeta3 in human myometrial cells.

Authors:  Miao Zhong; Dilyara A Murtazina; Jennifer Phillips; Chun-Ying Ku; Barbara M Sanborn
Journal:  Biol Reprod       Date:  2008-03-05       Impact factor: 4.285

9.  Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells.

Authors:  James T Sharkey; Roopashri Puttaramu; R Ann Word; James Olcese
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

10.  Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells.

Authors:  Hideo Ohira; Yoshio Fujioka; Chikae Katagiri; Mayumi Yano; Rie Mamoto; Michiko Aoyama; Makoto Usami; Masamichi Ikeda
Journal:  J Clin Biochem Nutr       Date:  2011-08-24       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.